Fig. 2From: DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutationComparison of CNA-based pattern, PD-L1 expression and survival analysis among PMBCL and three subgroups of DLBCL. a, Comparison of CNA-based patterns of driver genes among PMBCL and three subgroups of DLBCL according to the status of JAK2/PD-L2 amplification and MYD88 L265P mutation. b, Comparison of PD-L1 expression (IHC score) among PMBCL and three subgroups of DLBCL. c, Survival curves and cox-regression analysis of OS and PFS among three subgroups of DLBCL after RCHOP-like treatment. d, Representative images of HE(Ćā200) and PD-L1(Ćā200) IHC in DLBCL_JAK2/PD-L2_amp and DLBCL_ MYD88_L265PBack to article page